CLOs on the Move

Advocate Health Care

www.advocatehealth.org

 
Advocate Health is redefining how, when and where care is delivered to help people live well. We`re providing equitable care for all in our communities and using our combined strength and expertise to deliver better outcomes at a lower cost. Headquartered in Charlotte, North Carolina, we have a combined footprint across six states – Alabama, Georgia, Illinois, North Carolina, South Carolina and Wisconsin – and maintain a strong organizational presence in Chicago and Milwaukee.
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Octave

Octave Health is the nation`s first practice supporting all aspects of emotional well-being.

VASAMED, Inc.

VASAMED, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Eden Prairie, MN. To find more information about VASAMED, Inc., please visit www.vasamed.com

Emedikon

Emedikon is a Ocala, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hospice by the Sea

Hospice by the Sea is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Humacyte

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.